Fondaparinux in acute heparin-induced thrombocytopenia: a case series

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 12, 2011, Pages 2501-2503

  Goldfarb, M J ^a   Blostein, M D ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FONDAPARINUX; THROMBIN ANTITHROMBIN COMPLEX; WARFARIN;

ACUTE DISEASE; ADULT; AGED; ASSAY; BLEEDING; CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; FEMALE; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LEG AMPUTATION; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONIN RELEASE ASSAY; STROKE; SURGICAL PATIENT; TISSUE NECROSIS;

ANTICOAGULANTS; BLOOD CHEMICAL ANALYSIS; FEMALE; HEPARIN; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PLATELET FACTOR 4; POLYSACCHARIDES; SEROTONIN; THROMBOCYTOPENIA;

EID: 82755189073     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04489.x     Document Type: Letter

References (14)

1. Warkentin TE. Fondaparinux: does it cause HIT? Can it treat HIT? Expert Rev Hematol 2010; 3: 567-81.
2. Rota E, Bazzan M, Fantino G. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT). Thromb Haemost 2008; 99: 779-81.
3. Salem M, Elrefai S, Shrit MA, Warkentin TE. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke. Thromb Haemost 2010; 104: 1071-2.
4. Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 2007; 356: 2653-5.
5. Savi P, Chong BH, Greinacher A, Gruel Y, Kelton JG, Warkentin TE, Eichler P, Meuleman D, Petitou M, Herault JP, Cariou R, Herbert JM. Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin. Blood 2005; 105: 139-44.
6. Grouzi E, Kyriakou E, Panagou I, Spiliotopoulou I. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience. Clin Appl Thromb Hemost 2010; 16: 663-7.
7. Lobo B, Finch C, Howard A, Minhas S. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia. Thromb Haemost 2008; 99: 208-14.
8. Pappalardo F, Scandroglio A, Maj G, Zangrillo A, D'Angelo A. Treatment of heparin-induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux. J Thorac Cardiovasc Surg 2010; 139: 790-2.
9. Kuo KH, Kovacs MJ. Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux. Thromb Haemost 1995; 93: 999-1000.
10. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytophenia. Blood 1986; 67: 27-30.
11. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4: 759-765.
12. Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost 2010; 6: 1304-12.
13. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl. 6): 340S-80S.
14. Warkentin TE, Pai M, Sheppard JI, Schulman S, Spyropoulosr AC, Eikelboom JW. Fondaparinux treatment of acute heparin-induced thrombocytopenia (HIT) confirmed by a positive serotonin-release assay a 30-month, 16-patient case series. J Thromb Haemost 2011; 9: 2389-96.